Veronique Baud

Dr. Veronique Baud

INSERM, Université de Paris
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2001 in Trends in Cell Biology
Verified
Journal Article
Closed access
Veronique BaudVeronique Baud
Veronique Baud
MKMichael Karin
Michael Karin

1 January 2009 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
Veronique BaudVeronique Baud
Veronique Baud
MKMichael Karin
Michael Karin

9 April 1999 in Science
Verified
Journal Article
Closed access
PDF file
YHYinling Hu
Yinling Hu
Veronique BaudVeronique Baud
Veronique Baud
MDMireille Delhase
Mireille Delhase
PZPeilin Zhang
Peilin Zhang
TDThomas Deerinck
Thomas Deerinck
MKMichael Karin
Michael Karin
The oligomeric IκB kinase (IKK) is composed of three polypeptides: IKKα and IKKβ, the catalytic subunits, and IKKγ, a regulatory subunit. IKKα and IKKβ are similar in structure and thought to have similar function—phosphorylation of the IκB inhibitors in response to proinflammatory stimuli. Such phosphorylation leads to degradation of IκB and activation of nuclear factor κB transcription factors. The physiological function of these protein kinases was explored by analysis of IKKα-deficient mice. IKKα was not required for activation of IKK and degradation of IκB by proinflammatory stimuli. Instead, loss of IKKα interfered with multiple morphogenetic events, including limb and skeletal patterning and proliferation and differentiation of epidermal keratinocytes.

15 May 1999 in Genes & Development
Verified
Journal Article
Open access
PDF file
Veronique BaudVeronique Baud
Veronique Baud
ZLZheng-Gang Liu
Zheng-Gang Liu
BBBrydon Bennett
Brydon Bennett
NSNobutaka Suzuki
Nobutaka Suzuki
YXYing Xia
Ying Xia
MKMichael Karin
Michael Karin
Interleukin-1 (IL-1) and tumor necrosis factor (TNF-α) stimulate transcription factors AP-1 and NF-κB through activation of the MAP kinases JNK and p38 and the IκB kinase (IKK), respectively. The TNF-α and IL-1 signals are transduced through TRAF2 and TRAF6, respectively. Overexpressed TRAF2 or TRAF6 activate JNK, p38, or IKK in the absence of extracellular stimulation. By replacing the carboxy-terminal TRAF domain of TRAF2 and TRAF6 with repeats of the immunophilin FKBP12, we demonstrate that their effector domains are composed of their amino-terminal Zn and RING fingers. Oligomerization of the TRAF2 effector domain results in specific binding to MEKK1, a protein kinase capable of JNK, p38, and IKK activation, and induction of TNF-α and IL-1 responsive genes. TNF-α also enhances the binding of native TRAF2 to MEKK1 and stimulates the kinase activity of the latter. Thus, TNF-α and IL-1 signaling is based on oligomerization of TRAF2 and TRAF6 leading to activation of effector kinases.

8 May 2011 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
NDNicolas F Delahaye
Nicolas F Delahaye
SRSylvie Rusakiewicz
Sylvie Rusakiewicz
IMIsabelle Martins
Isabelle Martins
CMCédric Ménard
Cédric Ménard
SRStephan Roux
Stephan Roux
LZLaurence Zitvogel
Laurence Zitvogel

16 November 1998 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
AAArie Abo
Arie Abo
JQJian Qu
Jian Qu
MCMarta S. Cammarano
Marta S. Cammarano
CDChuntao Dan
Chuntao Dan
AFAlexandra Fritsch
Alexandra Fritsch
AMAudrey Minden
Audrey Minden
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.